The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Recurrent chromosomal abnormalities in human embryonic stem cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adaptation to culture of human embryonic stem cells and oncogenesis in vivo
Baker, D. E. C., Harrison, N. J., Maltby, E., Smith, K., Moore, H. D., Shaw, P. J., Heath, P. R., Holden, H., & Andrews, P. W. (2007) · Nature Biotechnology · doi:10.1038/nbt1285 · Cited by 636
Genomic alterations in cultured human embryonic stem cells
Maitra, A., Arking, D. E., Shivapurkar, N., Ikeda, M., Stastny, V., Kassauei, K., Sui, G., Cutler, D. J., Liu, Y., Brimble, S. N., et al. (2005) · Nature Genetics · doi:10.1038/ng1631 · Cited by 619
Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations
Pfeiffer, P. (2000) · Mutagenesis · doi:10.1093/mutage/15.4.289 · Cited by 462
Scotto, L., Narayan, G., Nandula, S. V., Arias‐Pulido, H., Subramaniyam, S., Schneider, A., Kaufmann, A. M., Wright, J. D., Pothuri, B., Mansukhani, M., et al. (2008) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20577 · Cited by 333
Mateizel, I., De Temmerman, N., Ullmann, U., Cauffman, G., Sermon, K., Van de Velde, H., De Rycke, M., Degreef, E., Devroey, P., Liebaers, I., et al. (2006) · Human Reproduction · doi:10.1093/humrep/dei345 · Cited by 237
Self-citationLukusa, T., & Fryns, J. P. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2007.10.005 · Cited by 205
CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells
Herszfeld, D., Wolvetang, E. J., Langton-Bunker, E., Chung, T.-L., Filipczyk, A. A., Houssami, S., Jamshidi, P., Koh, K. L. L., Laslett, A. L., Michalska, A., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1197 · Cited by 152
Inzunza, J. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah051 · Cited by 140
Camps, J., Grade, M., Nguyen, Q. T., Hörmann, P., Becker, S., Hummon, A. B., Rodriguez, V., Chandrasekharappa, S. C., Chen, Y., Difilippantonio, M. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2864 · Cited by 84
Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q
Yin, Z., Babaian, R. J., Troncoso, P., Strom, S. S., Spitz, M. R., Caudell, J. J., Stein, J. D., & Kagan, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204310 · Cited by 67
Cited by
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Laurent, L. C., Ulitsky, I., Slavin, I., Tran, H., Schork, A., Morey, R., Lynch, C., Harness, J. V., Lee, S., Barrero, M. J., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2010.12.003 · Cited by 890
The tumorigenicity of human embryonic and induced pluripotent stem cells
Ben-David, U., & Benvenisty, N. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3034 · Cited by 889
Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies
Lee, A. S., Tang, C., Rao, M. S., Weissman, I. L., & Wu, J. C. (2013) · Nature Medicine · doi:10.1038/nm.3267 · Cited by 727
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells
Yusa, K., Rashid, S. T., Strick-Marchand, H., Varela, I., Liu, P.-Q., Paschon, D. E., Miranda, E., Ordóñez, A., Hannan, N. R. F., Rouhani, F. J., et al. (2011) · Nature · doi:10.1038/nature10424 · Cited by 639
Initiative, T. I. S. C. (2011) · Nature Biotechnology · doi:10.1038/nbt.2051 · Cited by 577
Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model Disease
Saha, K., & Jaenisch, R. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.11.009 · Cited by 411
Urbach, A., Bar-Nur, O., Daley, G. Q., & Benvenisty, N. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.005 · Cited by 407
Human germ cell tumours from a developmental perspective
Oosterhuis, J. W., & Looijenga, L. H. J. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0178-9 · Cited by 328
A reference human induced pluripotent stem cell line for large-scale collaborative studies
Pantazis, C. B., Yang, A., Lara, E., McDonough, J. A., Blauwendraat, C., Peng, L., Oguro, H., Kanaujiya, J., Zou, J., Sebesta, D., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.11.004 · Cited by 310
Characterization of human embryonic stem cells with features of neoplastic progression
Werbowetski-Ogilvie, T. E., Bossé, M., Stewart, M., Schnerch, A., Ramos-Mejia, V., Rouleau, A., Wynder, T., Smith, M.-J., Dingwall, S., Carter, T., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1516 · Cited by 278
Närvä, E., Autio, R., Rahkonen, N., Kong, L., Harrison, N., Kitsberg, D., Borghese, L., Itskovitz-Eldor, J., Rasool, O., Dvorak, P., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1615 · Cited by 277
Recurrent copy number variations in human induced pluripotent stem cells
Martins-Taylor, K., Nisler, B. S., Taapken, S. M., Compton, T., Crandall, L., Montgomery, K. D., Lalande, M., & Xu, R.-H. (2011) · Nature Biotechnology · doi:10.1038/nbt.1890 · Cited by 213
Higher-Density Culture in Human Embryonic Stem Cells Results in DNA Damage and Genome Instability
Jacobs, K., Zambelli, F., Mertzanidou, A., Smolders, I., Geens, M., Nguyen, H. T., Barbé, L., Sermon, K., & Spits, C. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.01.015 · Cited by 82
“Nevertheless, these cultures are frequently taken over by cells carrying genetic abnormalities, some of which are highly recurrent (Amps et al., 2011; Lund et al., 2012; Nguyen et al., 2013; Spits et al., 2008).”
BackgroundSelf-citationGain of 20q11.21 in Human Pluripotent Stem Cells Impairs TGF-β-Dependent Neuroectodermal Commitment
Markouli, C., Couvreu De Deckersberg, E., Regin, M., Nguyen, H. T., Zambelli, F., Keller, A., Dziedzicka, D., De Kock, J., Tilleman, L., Van Nieuwerburgh, F., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.05.005 · Cited by 64
Self-citationDeveloping defined substrates for stem cell culture and differentiation
Hagbard, L., Cameron, K., August, P., Penton, C., Parmar, M., Hay, D. C., & Kallur, T. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2017.0230 · Cited by 62
Low-grade chromosomal mosaicism in human somatic and embryonic stem cell populations
Jacobs, K., Mertzanidou, A., Geens, M., Thi Nguyen, H., Staessen, C., & Spits, C. (2014) · Nature Communications · doi:10.1038/ncomms5227 · Cited by 41
Self-citationRebuzzini, P., Zuccotti, M., Redi, C. A., & Garagna, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2171-8 · Cited by 35
Geens, M., Seriola, A., Barbé, L., Santalo, J., Veiga, A., Dée, K., Van Haute, L., Sermon, K., & Spits, C. (2016) · Molecular Human Reproduction · doi:10.1093/molehr/gaw004 · Cited by 26
“For example, VUB03 and VUB04 have been shown to carry a normal karyotype even at later passages than those investigated in this study (Supplementary Table SV) (Spits et al., 2008; Nguyen et al., 2014b).”
BackgroundSelf-citationKeller, A., Tilleman, L., Dziedzicka, D., Zambelli, F., Sermon, K., Van Nieuwerburgh, F., Spits, C., & Geens, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-51314-6 · Cited by 21
Self-citationQuality of cell products: authenticity, identity, genomic stability and status of differentiation
Dittmar, K. E. J., Simann, M., Zghoul, N., Schön, O., Meyring, W., Hannig, H., Macke, L., Dirks, W. G., Miller, K., Garritsen, H. S. P., et al. (2010) · Transfusion Medicine and Hemotherapy · doi:10.1159/000284401 · Cited by 24
Metadata
- Authors
- Spits, C., Mateizel, I., Geens, M., Mertzanidou, A., Staessen, C., Vandeskelde, Y., Van der Elst, J., Liebaers, I., & Sermon, K.
- Venue
- Nature Biotechnology
- Published
- 2008-11-23
- Volume
- 26
- Issue
- 12
- Pages
- 1361-1363
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2003935383
- Cited by
- 259
- References
- 13
- FWCI
- 13.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.